Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net income	$ 4,213,476	$ 2,906,901
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	771,030	676,324
Amortization of operating right of use asset	43,019	312,826
Stock compensation expense	315,216	320,199
Bad debt expense	1,200,000	391,667
Gain on disposal of assets	0	(24,737)
Loss on sale of property and equipment	0	107,820
(Increase) decrease in:
Accounts receivables	86,972	198,430
Long-term receivables, prepaids and other assets	655,391	(414,998)
Increase (decrease) in:
Accounts payable	(309,812)	26,210
Operating lease liability	(39,777)	(306,798)
Accrued liabilities	122,744	52,441
Deferred revenue	7,631	(213,321)
Net cash provided by operating activities	7,065,890	4,032,964
Cash flows from investing activities:
Sale of property and equipment	0	1,374,085
Capitalization of software costs	(769,243)
Purchase of property and equipment	(133,944)	(50,823)
Net cash provided by (used in) investing activities	(903,187)	1,323,262
Cash flows from financing activities:
Net (decrease) increase in lines of credit	(2,590,907)	(2,614,133)
Common Stock buyback/retirement	(981,194)	(5,212,452)
Proceeds from employee stock plan	92,728	109,177
Dividends paid	(993,037)	(439,833)
Payments on notes payable and capital leases	(209,748)	0
Net cash used in financing activities	(4,682,158)	(8,157,241)
Net increase (decrease) in cash and cash equivalents	1,480,545	(2,801,015)
Cash and cash equivalents at beginning of period	21,460,948	24,070,322
Cash and cash equivalents at end of period	22,941,493	21,269,307
Supplemental disclosure of cash flow information:
Cash paid for income taxes	264,486	172,342
Cash paid for interest	52,481	21,607
Cash paid for operating leases	$ 53,015	$ 66,871
Supplemental disclosure of non-cash investing and financing activities:
Common stock to pay accrued liabilities (in shares)	256,977	234,447
Dividends accrued on preferred stock	$ 489,833	$ 439,833